• Explore /
  • Poster
  • / VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [<sup>161</sup>Tb]Tb-PSMA-I&T.

VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T.

Abstract Poster

Authors

null

James Patrick Buteau

Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre; and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia

James Patrick Buteau , Louise Kathleen Kostos , Ramin Alipour , Price Jackson , Lachlan McIntosh , Brittany Emmerson , Mohammad B Haskali , Theresa Yeung , Sophia Xie , Elizabeth Medhurst , Rajeev Ravi , Brian D. Gonzalez , Heidi Fettke , Nicole Ng , Maria Docanto , Patricia Bukczynska , Benjamin Blyth , Luc Furic , Arun Azad , Michael S Hofman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05521412

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS281)

DOI

10.1200/JCO.2023.41.6_suppl.TPS281

Abstract #

TPS281

Poster Bd #

Q3

Abstract Disclosures

Similar Posters

First Author: Colin P Bergstrom

First Author: Guilhem Roubaud

First Author: Louise Kathleen Kostos

First Author: Mark N. Stein